Development of the prediction marker and the preemptive therapy for chronic GVHD based on abnormal B cell homeostasis during the acute phase of allogeneic HSCT

异基因HSCT急性期B细胞稳态异常的慢性GVHD预测标记物开发及抢先治疗

基本信息

  • 批准号:
    20K08753
  • 负责人:
  • 金额:
    $ 2.75万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2020
  • 资助国家:
    日本
  • 起止时间:
    2020-04-01 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Graft-versus-host disease: current understanding of immune pathogenesis and clinical treatment
移植物抗宿主病:免疫发病机制和临床治疗的最新认识
  • DOI:
    10.11406/rinketsu.62.1281
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yanada M;Konuma T;Yamasaki S;Mizuno S;Hirabayashi S;Nishiwaki S;Uchida N;Doki N;Tanaka M;Ozawa Y;Sawa M;Eto T;Kawakita T;Ota S;Fukuda T;Onizuka M;Kimura T;Atsuta Y;Kako S;Yano S;松岡賢市
  • 通讯作者:
    松岡賢市
GVHDの予防と治療の新たな展開
GVHD防治新进展
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yasu T;Konuma T;Oiwa-Monna M;Takahashi S;Nannya Y;Tojo A;松岡賢市
  • 通讯作者:
    松岡賢市
Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease
  • DOI:
    10.1038/s41409-020-01100-0
  • 发表时间:
    2020-10-30
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Iwamoto, Miki;Ikegawa, Shuntaro;Matsuoka, Ken-ichi
  • 通讯作者:
    Matsuoka, Ken-ichi
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matsuoka Ken-ichi其他文献

Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes
急性髓系白血病和骨髓增生异常综合征患者异基因造血细胞移植后结局的差异
  • DOI:
    10.1080/10428194.2021.1961242
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yanada Masamitsu;Mizuno Shohei;Yamasaki Satoshi;Harada Kaito;Konuma Takaaki;Tamaki Hiroya;Shingai Naoki;Uchida Naoyuki;Ozawa Yukiyasu;Tanaka Masatsugu;Onizuka Makoto;Sawa Masashi;Nakamae Hirohisa;Shiratori Souichi;Matsuoka Ken-ichi;Eto Tetsuya;Kawakita To
  • 通讯作者:
    Kawakita To
Comparison of reduced-intensity/toxicity conditioning regimens for umbilical cord blood transplantation for lymphoid malignancies
脐带血移植治疗淋巴恶性肿瘤的降低强度/毒性预处理方案的比较
  • DOI:
    10.1038/s41409-020-0905-6
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Imahashi Nobuhiko;Terakura Seitaro;Kondo Eisei;Kako Shinichi;Uchida Naoyuki;Kobayashi Hikaru;Inamoto Yoshihiro;Sakai Hitoshi;Tanaka Masatsugu;Ishikawa Jun;Kozai Yasuji;Matsuoka Ken-ichi;Kimura Takafumi;Fukuda Takahiro;Atsuta Yoshiko;Kanda Junya
  • 通讯作者:
    Kanda Junya
Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial)
CML-CP 患者对伊马替尼主要分子反应中转用尼洛替尼的疗效和安全性:多中心 II 期试验(NILSw 试验)的结果
  • DOI:
    10.1007/s12185-018-2401-y
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Ishikawa Jun;Matsumura Itaru;Kawaguchi Tatsuya;Kuroda Junya;Nakamae Hirohisa;Miyamoto Toshihiro;Matsuoka Ken-ichi;Shibayama Hirohiko;Hino Masayuki;Hirase Chikara;Kamimura Tomohiko;Shimose Takayuki;Akashi Koichi;Kanakura Yuzuru
  • 通讯作者:
    Kanakura Yuzuru

Matsuoka Ken-ichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matsuoka Ken-ichi', 18)}}的其他基金

Development of a novel algorithm for immune regulation that enables the active Treg amplification soon after HSCT
开发一种新的免疫调节算法,可在 HSCT 后立即实现主动 Treg 扩增
  • 批准号:
    17K09954
  • 财政年份:
    2017
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The pathophysiology and therapeutic approaches of graft-versus-host disease following allogeneic hematopoietic stem cell transplantation with a focus on the role of oral microbiota.
异基因造血干细胞移植后移植物抗宿主病的病理生理学和治疗方法,重点关注口腔微生物群的作用。
  • 批准号:
    23K15301
  • 财政年份:
    2023
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Psychological and social support for patients and their family members after hematopoietic stem cell transplantation who visit multiple outpatient clinics
为造血干细胞移植后到多个门诊就诊的患者及其家属提供心理和社会支持
  • 批准号:
    23K16481
  • 财政年份:
    2023
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of dynamics of immune reconstruction after hematopoietic stem cell transplantation by single-cell analysis of multi-timepoint samples
通过多时间点样本的单细胞分析阐明造血干细胞移植后免疫重建的动态
  • 批准号:
    23KJ1899
  • 财政年份:
    2023
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Early detection of pulmonary complications of hematopoietic stem-cell transplantation in children using hyperpolarized xenon MRI
超极化氙MRI早期发现儿童造血干细胞移植肺部并发症
  • 批准号:
    10563271
  • 财政年份:
    2023
  • 资助金额:
    $ 2.75万
  • 项目类别:
Exploratory research on the usefulness of trophic pathways in allogeneic hematopoietic stem cell transplantation
营养途径在异基因造血干细胞移植中作用的探索性研究
  • 批准号:
    22K18237
  • 财政年份:
    2022
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients
IL-33诱导产生IL-9的2型先天淋巴细胞在调节儿科患者造血干细胞移植(HSCT)后急性肺损伤中的作用
  • 批准号:
    10540768
  • 财政年份:
    2022
  • 资助金额:
    $ 2.75万
  • 项目类别:
IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients
IL-33诱导产生IL-9的2型先天淋巴细胞在儿科患者造血干细胞移植(HSCT)后急性肺损伤的调节中
  • 批准号:
    10392134
  • 财政年份:
    2022
  • 资助金额:
    $ 2.75万
  • 项目类别:
Novel non-genotoxic ligand-based CD117-directed CAR T conditioning in the context of hematopoietic stem cell transplantation and leukemia treatment
造血干细胞移植和白血病治疗背景下新型非基因毒性配体 CD117 定向 CAR T 调理
  • 批准号:
    10613307
  • 财政年份:
    2022
  • 资助金额:
    $ 2.75万
  • 项目类别:
Devleopment of new xenogeneic hematopoietic stem cell chimeras by in utero hematopoietic stem cell transplantation
通过宫内造血干细胞移植开发新型异种造血干细胞嵌合体
  • 批准号:
    21K15003
  • 财政年份:
    2021
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了